Strategy: 340B Rebate Model Pilot Launched Jan 2026 — FQHCs Must Adapt Pharmacy Workflows
HRSA's first-ever 340B rebate model pilot launched January 1, 2026 with 8 manufacturers and 10 drugs (Eliquis, Enbrel, Jardiance, Stelara). Instead of upfront discounts, FQHCs must buy at wholesale and submit rebate claims within 45 days. This changes cash-flow timing and requires two parallel workflows. Action: (1) Audit current 340B capture rates — most FQHCs capture only 20-30% of eligible prescriptions. (2) Invest in 340B software integrating with your EHR. (3) Model cash-flow scenarios for delayed rebate timing. (4) Review contract pharmacy relationships — strategic partners generate significantly more revenue.
Key takeaways
- HRSA 340B rebate model pilot launched Jan 1, 2026 — 8 manufacturers, 10 drugs (Eliquis, Enbrel, Jardiance, Stelara)
- FQHCs must now buy at wholesale and submit rebate claims within 45 days — changes cash-flow timing
- Most FQHCs capture only 20-30% of eligible 340B prescriptions — audit current capture rates
- Invest in 340B software integrating with your EHR and model cash-flow scenarios for delayed rebate timing
Primary source
Community Link ConsultingFQHC Talent. (2026, March 4). Strategy: 340B Rebate Model Pilot Launched Jan 2026 — FQHCs Must Adapt Pharmacy Workflows. Primary source: Community Link Consulting. Retrieved April 28, 2026, from https://www.fqhctalent.com/intel/strategy-340b-rebate-model-pivot
More in Strategy & Tactics
Apr 17
CHCF Brief: Assisted Living as Housing Solution for Californians with Behavioral Health Needs
Apr 13
IEHP Opens 33,000 sq-ft Community Wellness Center in San Bernardino — Free Programming Open to Members and Non-Members
Apr 10
CHCF Publishes 'Six Bold Ideas for the Future of Medi-Cal' — Including Unified Primary Care Payment Model
Apr 9
CHCF Hosting April 16 Policy Briefing on AI Implementation in Safety-Net Health Centers